Cargando…
S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428320/ http://dx.doi.org/10.1097/01.HS9.0000967960.99850.6d |
_version_ | 1785090439694516224 |
---|---|
author | Roddie, Claire Sandhu, Karamjeet Tholouli, Eleni Shaughnessy, Paul Barba Suñol, Pere Nuno Direito de Morais Guerreiro, Manuel Abedi, Mehrdad Bishop, Michael Yared, Jean Ghobadi, Armin Yallop, Deborah Logan, Aaron Amer, Beitinjaneh Pantin, Jeremy Arellano, Martha L Chaganti, Sridhar Malladi, Ram Menne, Tobias Escamilla, Virginia Hodby, Katharine Gundabolu, Krishna Mountjoy, Luke Odwyer, Kristen Abedin, Sameem Alkhateeb, Hassan Shah, Bijal Basilico, Silvia Cluxton, Deborah Dawes, Joanna Lao-Sirieix, Pierre Raymond, Meera Shang, Justin Hu, Yanqing Pittari, Gianfranco Saxena, Kapil Brugger, Wolfram Zhang, Y Pule, Martin Park, Daniel De Angelo, Daniel Jabbour, Elias |
author_facet | Roddie, Claire Sandhu, Karamjeet Tholouli, Eleni Shaughnessy, Paul Barba Suñol, Pere Nuno Direito de Morais Guerreiro, Manuel Abedi, Mehrdad Bishop, Michael Yared, Jean Ghobadi, Armin Yallop, Deborah Logan, Aaron Amer, Beitinjaneh Pantin, Jeremy Arellano, Martha L Chaganti, Sridhar Malladi, Ram Menne, Tobias Escamilla, Virginia Hodby, Katharine Gundabolu, Krishna Mountjoy, Luke Odwyer, Kristen Abedin, Sameem Alkhateeb, Hassan Shah, Bijal Basilico, Silvia Cluxton, Deborah Dawes, Joanna Lao-Sirieix, Pierre Raymond, Meera Shang, Justin Hu, Yanqing Pittari, Gianfranco Saxena, Kapil Brugger, Wolfram Zhang, Y Pule, Martin Park, Daniel De Angelo, Daniel Jabbour, Elias |
author_sort | Roddie, Claire |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104283202023-08-17 S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY Roddie, Claire Sandhu, Karamjeet Tholouli, Eleni Shaughnessy, Paul Barba Suñol, Pere Nuno Direito de Morais Guerreiro, Manuel Abedi, Mehrdad Bishop, Michael Yared, Jean Ghobadi, Armin Yallop, Deborah Logan, Aaron Amer, Beitinjaneh Pantin, Jeremy Arellano, Martha L Chaganti, Sridhar Malladi, Ram Menne, Tobias Escamilla, Virginia Hodby, Katharine Gundabolu, Krishna Mountjoy, Luke Odwyer, Kristen Abedin, Sameem Alkhateeb, Hassan Shah, Bijal Basilico, Silvia Cluxton, Deborah Dawes, Joanna Lao-Sirieix, Pierre Raymond, Meera Shang, Justin Hu, Yanqing Pittari, Gianfranco Saxena, Kapil Brugger, Wolfram Zhang, Y Pule, Martin Park, Daniel De Angelo, Daniel Jabbour, Elias Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428320/ http://dx.doi.org/10.1097/01.HS9.0000967960.99850.6d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Oral Sessions Roddie, Claire Sandhu, Karamjeet Tholouli, Eleni Shaughnessy, Paul Barba Suñol, Pere Nuno Direito de Morais Guerreiro, Manuel Abedi, Mehrdad Bishop, Michael Yared, Jean Ghobadi, Armin Yallop, Deborah Logan, Aaron Amer, Beitinjaneh Pantin, Jeremy Arellano, Martha L Chaganti, Sridhar Malladi, Ram Menne, Tobias Escamilla, Virginia Hodby, Katharine Gundabolu, Krishna Mountjoy, Luke Odwyer, Kristen Abedin, Sameem Alkhateeb, Hassan Shah, Bijal Basilico, Silvia Cluxton, Deborah Dawes, Joanna Lao-Sirieix, Pierre Raymond, Meera Shang, Justin Hu, Yanqing Pittari, Gianfranco Saxena, Kapil Brugger, Wolfram Zhang, Y Pule, Martin Park, Daniel De Angelo, Daniel Jabbour, Elias S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY |
title | S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY |
title_full | S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY |
title_fullStr | S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY |
title_full_unstemmed | S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY |
title_short | S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE PIVOTAL FELIX STUDY |
title_sort | s262: safety and efficacy of obecabtagene autoleucel (obe-cel), a fast-off rate cd19 car in relapsed/refractory adult b-cell acute lymphoblastic leukaemia:top line results of the pivotal felix study |
topic | Oral Sessions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428320/ http://dx.doi.org/10.1097/01.HS9.0000967960.99850.6d |
work_keys_str_mv | AT roddieclaire s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT sandhukaramjeet s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT tholoulieleni s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT shaughnessypaul s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT barbasunolpere s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT nunodireitodemoraisguerreiromanuel s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT abedimehrdad s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT bishopmichael s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT yaredjean s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT ghobadiarmin s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT yallopdeborah s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT loganaaron s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT amerbeitinjaneh s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT pantinjeremy s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT arellanomarthal s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT chagantisridhar s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT malladiram s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT mennetobias s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT escamillavirginia s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT hodbykatharine s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT gundabolukrishna s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT mountjoyluke s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT odwyerkristen s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT abedinsameem s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT alkhateebhassan s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT shahbijal s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT basilicosilvia s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT cluxtondeborah s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT dawesjoanna s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT laosirieixpierre s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT raymondmeera s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT shangjustin s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT huyanqing s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT pittarigianfranco s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT saxenakapil s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT bruggerwolfram s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT zhangy s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT pulemartin s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT parkdaniel s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT deangelodaniel s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy AT jabbourelias s262safetyandefficacyofobecabtageneautoleucelobecelafastoffratecd19carinrelapsedrefractoryadultbcellacutelymphoblasticleukaemiatoplineresultsofthepivotalfelixstudy |